Member Info for 1pencil

Its within a whisker of 0.5%, possible worked order, short side ?

Agreed, however THG Beauty can list in the US or better still find a partner where there are compelling synergies, imo this wouldn't be too hard given how current market leaders are outlet based for much of their sales, i.e non D2C

The board has self imposed time lines for this year, although I accept these may change given the world is now upside down.

Some reasons;

1. THG Beauty would obtain a higher valuation if US listed, either with or without a partner.

2. The above would pull up the THG's own valuation as it would still own a controlling interest enabling it to do other things with its paper (if needed).

3. Most of THG's investors are overseas, the IPO was certainly aimed at US investors to begin with.

4. Dermstore may help underpin a US valuation, unlikely in the UK

5. THG is currently investing/expanding in the US, further underpins valuation.

As mentioned before, establishing a quality service using Ingenuity in the US is going to be a herculean task, better undertaken perhaps with a resident (and listed) partner.

..just my musings

elf just reported beating forecasts whilst raising 2023 guidance, trading up 5% after the bell.

These valuations confirm THG has to either list Beauty division in the US or find an already listed US company to partner with, elf for example derives most of its revenue from walk in stores or other outlets, could be a good marriage with THG Beauty underpinned by Ingenuity.

Dermstore is another reason, a well known and established US brand which helps underpin the valuation.

https://finance.yahoo.com/news/e-l-f-beauty-announces-200500228.html

Good numbers from elf although how much of that is in the price already, market cap $1.7b trading at close to all time high.

Growth across the top three picks are expected to be pretty similar ranging from 18 - 22%, elf, nu skin and Ulta

For the first time whey prices are now below 2021 levels at 900 euros per metric ton, Aug 2021 - 928 euros.

https://www.clal.it/en/index.php?section=siero_olanda

If the existing RB holders felt there was more chance of a recovery by selling rather than going it alone that may work, similar with THG it mostly has the infrastructure in place now need to scale it as quickly as possible,

RB's largest shareholder in Jupiter at 18%, THG has a Jupiter/Chrysalis supportive holder.

THG could apply all sorts of cost saving synergies if they were to acquire Rev Beauty, one to watch anyway.

btw, have you seen what Goldman have been up to recently, for a company that only recently invested they sure are active - my thoughts are they must be making a two way market, i.e as a market maker or perhaps arb trading as some trades are US, others HK.

https://sc.hkexnews.hk/gb/di.hkex.com.hk/di/NSAllFormList.aspx?sa2=an&sid=344192&corpn=HUTCHMED+(China)+Ltd.&sd=03/08/2021&ed=03/08/2022&cid=0&sa1=cl&scsd=03%2f08%2f2021&sced=03%2f08%2f2022&sc=13&src=MAIN&lang=EN&g_lang=en&

Cheers Bernie, yup, everyone is feeling the pressure with markets in general disarray.

Jatw, hopefully much progress has been made by then. Shanghai factory completed helping ramp up production volumes, SHPL currently growing at 18% v H! 2021, very impressive, where will that little gem be in 2024 revenue wise.

Although still not comfortable with the boards hands off approach to buying shares, I feel the risk reward outweighs this slight negative, if I get the opportunity will buy back stock to take me back up to full weight.

Apologies if I got it wrong, can't remember the reason why I thought NoS was daveycaferacer on here, we had conversations back and forth so assumed it was the case. It was meant to be a friendly gesture.

Ditto Jatw, I tend to post where there is informed discussion, my handle is also the same but very few posts on a d v f n as the threads can be err.. well get out of hand.

For me its all about knowledge and filling those gaps (especially on biotech) where I lack information. There's also the chat aspect although I have noticed when share prices are down the mood music changes lol

Still working my way through yesterday's results but so far very impressed, surprised we have bounced today given Pelosi's visit.

Complaining about posters complaining just adds to the guff, why not use filters - much easier.

Rev Beauty, possible target for THG although not exactly sure where their focus is at the moment, could be nutrition.

elf reports in the US tomorrow, expect good numbers as aimed more at the cost conscious side of the market, also on song at the moment.

Sorry, 'consistent'

What?? you are NoS from advfn, nothing clever about that., just trying to be constant.

With regard to my answer, your question didn't explain that well.

"I know that now as we all do, but my point was why wasn't that known about when they submitted the NDA and stop calling me NoS just to appear to be clever."

Longfellows, based on jatw post below Japan are set to continue ?

"Interesting Q was why do they think Japan can continue with the sanet data submission.

A because they are Asian."

H2 brings into focus earlier commitments around either an IPO of Beauty division or strategic partner, in the absence of Softbank they have centre stage.

The US market is an interesting one with relatively small ecommerce sales than one would expect, both leading players (elf and Ulta) have around 14% and 21% respectively which leaves plenty of room for UK upstarts to come in.

Its going to take a while to get the infrastructure in place in order to make a difference, set against a backdrop of growth companies not currently being in favour, cash flow and CAPEX.

Talking of valuations, both elf and Ulta are bobbing around at all time highs.

I can see the reasoning behind that answer Jatw, but how long have the FDA had this guidance/criteria ?

Surely Hutchmed's team should have picked up on something so basic as ethnicity as a trial requirement, FDA would have known this when granting fast track status.

One that I have been watching for potential buyers, Revlon has been struggling for a while and may have been a concern due to supplier issues, most of the beauty stocks stateside have had a small pop - not sure if that's down to relief on Revlon news or general market sentiment.

I did wonder at one point if it may be holding THG back, either way good to see it getting resolved.

Revlon, Inc. (REV)
NYSE - Nasdaq Real Time Price. Currency in USD
9.62+5.15 (+115.12%)
As of 03:25PM EDT. Market open.

Pretty happy with those results showing good traction with building momentum, lots to digest next day or two along with analyst call.

NoS

"EMA indicated that the SANET studies were not representative of patients and medical practice in the EU16; and

o The requisite pre-approval on-site inspections are currently subject to restrictions in China.

· Discussions on the path forward are ongoing with U.S. and EU regulators."

Worth a read amongst all the doom and gloom

DIGITAL TRANSFORMATION BLOG/

11 July 2022

The resilience of the DTC model

https://www.thgingenuity.com/resources/blog/the-resilience-of-the-dtc-model

Nothing specific, that said sunscreen should be flying off the Ingenuity shelf given US temps at the moment.

CUSTOMER EXPERIENCE CASE STUDIES/

29 July 2022

THG Detect X Dermstore

https://www.thgingenuity.com/resources